Global Amphotericin B Liposome for Injection Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Amphotericin B Liposome for Injection is a antifungal liposomal formulation. Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
The global Amphotericin B Liposome for Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Amphotericin B Liposome for Injection Industry Forecast” looks at past sales and reviews total world Amphotericin B Liposome for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Amphotericin B Liposome for Injection sales for 2024 through 2030. With Amphotericin B Liposome for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amphotericin B Liposome for Injection industry.
This Insight Report provides a comprehensive analysis of the global Amphotericin B Liposome for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amphotericin B Liposome for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amphotericin B Liposome for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amphotericin B Liposome for Injection and breaks down the forecast by Specification, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amphotericin B Liposome for Injection.
United States market for Amphotericin B Liposome for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Amphotericin B Liposome for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Amphotericin B Liposome for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Amphotericin B Liposome for Injection players cover Gilead Sciences, SPH New Asia Pharmaceuticals, Jemincare, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Amphotericin B Liposome for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Specification:
What is the 10-year outlook for the global Amphotericin B Liposome for Injection market?
What factors are driving Amphotericin B Liposome for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amphotericin B Liposome for Injection market opportunities vary by end market size?
How does Amphotericin B Liposome for Injection break out by Specification, by Application?
Amphotericin B Liposome for Injection is a antifungal liposomal formulation. Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
The global Amphotericin B Liposome for Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Amphotericin B Liposome for Injection Industry Forecast” looks at past sales and reviews total world Amphotericin B Liposome for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Amphotericin B Liposome for Injection sales for 2024 through 2030. With Amphotericin B Liposome for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amphotericin B Liposome for Injection industry.
This Insight Report provides a comprehensive analysis of the global Amphotericin B Liposome for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amphotericin B Liposome for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amphotericin B Liposome for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amphotericin B Liposome for Injection and breaks down the forecast by Specification, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amphotericin B Liposome for Injection.
United States market for Amphotericin B Liposome for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Amphotericin B Liposome for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Amphotericin B Liposome for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Amphotericin B Liposome for Injection players cover Gilead Sciences, SPH New Asia Pharmaceuticals, Jemincare, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Amphotericin B Liposome for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Specification:
- 2mg
- 10mg
- 50mg
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gilead Sciences
- SPH New Asia Pharmaceuticals
- Jemincare
What is the 10-year outlook for the global Amphotericin B Liposome for Injection market?
What factors are driving Amphotericin B Liposome for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amphotericin B Liposome for Injection market opportunities vary by end market size?
How does Amphotericin B Liposome for Injection break out by Specification, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amphotericin B Liposome for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Amphotericin B Liposome for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Amphotericin B Liposome for Injection by Country/Region, 2019, 2023 & 2030
2.2 Amphotericin B Liposome for Injection Segment by Specification
2.2.1 2mg
2.2.2 10mg
2.2.3 50mg
2.3 Amphotericin B Liposome for Injection Sales by Specification
2.3.1 Global Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
2.3.2 Global Amphotericin B Liposome for Injection Revenue and Market Share by Specification (2019-2024)
2.3.3 Global Amphotericin B Liposome for Injection Sale Price by Specification (2019-2024)
2.4 Amphotericin B Liposome for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Amphotericin B Liposome for Injection Sales by Application
2.5.1 Global Amphotericin B Liposome for Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Amphotericin B Liposome for Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Amphotericin B Liposome for Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Amphotericin B Liposome for Injection Breakdown Data by Company
3.1.1 Global Amphotericin B Liposome for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Amphotericin B Liposome for Injection Sales Market Share by Company (2019-2024)
3.2 Global Amphotericin B Liposome for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Amphotericin B Liposome for Injection Revenue by Company (2019-2024)
3.2.2 Global Amphotericin B Liposome for Injection Revenue Market Share by Company (2019-2024)
3.3 Global Amphotericin B Liposome for Injection Sale Price by Company
3.4 Key Manufacturers Amphotericin B Liposome for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amphotericin B Liposome for Injection Product Location Distribution
3.4.2 Players Amphotericin B Liposome for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AMPHOTERICIN B LIPOSOME FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Amphotericin B Liposome for Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Amphotericin B Liposome for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Amphotericin B Liposome for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Amphotericin B Liposome for Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Amphotericin B Liposome for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Amphotericin B Liposome for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Amphotericin B Liposome for Injection Sales Growth
4.4 APAC Amphotericin B Liposome for Injection Sales Growth
4.5 Europe Amphotericin B Liposome for Injection Sales Growth
4.6 Middle East & Africa Amphotericin B Liposome for Injection Sales Growth
5 AMERICAS
5.1 Americas Amphotericin B Liposome for Injection Sales by Country
5.1.1 Americas Amphotericin B Liposome for Injection Sales by Country (2019-2024)
5.1.2 Americas Amphotericin B Liposome for Injection Revenue by Country (2019-2024)
5.2 Americas Amphotericin B Liposome for Injection Sales by Specification (2019-2024)
5.3 Americas Amphotericin B Liposome for Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amphotericin B Liposome for Injection Sales by Region
6.1.1 APAC Amphotericin B Liposome for Injection Sales by Region (2019-2024)
6.1.2 APAC Amphotericin B Liposome for Injection Revenue by Region (2019-2024)
6.2 APAC Amphotericin B Liposome for Injection Sales by Specification (2019-2024)
6.3 APAC Amphotericin B Liposome for Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amphotericin B Liposome for Injection by Country
7.1.1 Europe Amphotericin B Liposome for Injection Sales by Country (2019-2024)
7.1.2 Europe Amphotericin B Liposome for Injection Revenue by Country (2019-2024)
7.2 Europe Amphotericin B Liposome for Injection Sales by Specification (2019-2024)
7.3 Europe Amphotericin B Liposome for Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amphotericin B Liposome for Injection by Country
8.1.1 Middle East & Africa Amphotericin B Liposome for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Amphotericin B Liposome for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Amphotericin B Liposome for Injection Sales by Specification (2019-2024)
8.3 Middle East & Africa Amphotericin B Liposome for Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amphotericin B Liposome for Injection
10.3 Manufacturing Process Analysis of Amphotericin B Liposome for Injection
10.4 Industry Chain Structure of Amphotericin B Liposome for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amphotericin B Liposome for Injection Distributors
11.3 Amphotericin B Liposome for Injection Customer
12 WORLD FORECAST REVIEW FOR AMPHOTERICIN B LIPOSOME FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Amphotericin B Liposome for Injection Market Size Forecast by Region
12.1.1 Global Amphotericin B Liposome for Injection Forecast by Region (2025-2030)
12.1.2 Global Amphotericin B Liposome for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Amphotericin B Liposome for Injection Forecast by Specification (2025-2030)
12.7 Global Amphotericin B Liposome for Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Amphotericin B Liposome for Injection Product Portfolios and Specifications
13.1.3 Gilead Sciences Amphotericin B Liposome for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 SPH New Asia Pharmaceuticals
13.2.1 SPH New Asia Pharmaceuticals Company Information
13.2.2 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Product Portfolios and Specifications
13.2.3 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 SPH New Asia Pharmaceuticals Main Business Overview
13.2.5 SPH New Asia Pharmaceuticals Latest Developments
13.3 Jemincare
13.3.1 Jemincare Company Information
13.3.2 Jemincare Amphotericin B Liposome for Injection Product Portfolios and Specifications
13.3.3 Jemincare Amphotericin B Liposome for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jemincare Main Business Overview
13.3.5 Jemincare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amphotericin B Liposome for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Amphotericin B Liposome for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Amphotericin B Liposome for Injection by Country/Region, 2019, 2023 & 2030
2.2 Amphotericin B Liposome for Injection Segment by Specification
2.2.1 2mg
2.2.2 10mg
2.2.3 50mg
2.3 Amphotericin B Liposome for Injection Sales by Specification
2.3.1 Global Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
2.3.2 Global Amphotericin B Liposome for Injection Revenue and Market Share by Specification (2019-2024)
2.3.3 Global Amphotericin B Liposome for Injection Sale Price by Specification (2019-2024)
2.4 Amphotericin B Liposome for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Amphotericin B Liposome for Injection Sales by Application
2.5.1 Global Amphotericin B Liposome for Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Amphotericin B Liposome for Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Amphotericin B Liposome for Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Amphotericin B Liposome for Injection Breakdown Data by Company
3.1.1 Global Amphotericin B Liposome for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Amphotericin B Liposome for Injection Sales Market Share by Company (2019-2024)
3.2 Global Amphotericin B Liposome for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Amphotericin B Liposome for Injection Revenue by Company (2019-2024)
3.2.2 Global Amphotericin B Liposome for Injection Revenue Market Share by Company (2019-2024)
3.3 Global Amphotericin B Liposome for Injection Sale Price by Company
3.4 Key Manufacturers Amphotericin B Liposome for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amphotericin B Liposome for Injection Product Location Distribution
3.4.2 Players Amphotericin B Liposome for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AMPHOTERICIN B LIPOSOME FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Amphotericin B Liposome for Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Amphotericin B Liposome for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Amphotericin B Liposome for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Amphotericin B Liposome for Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Amphotericin B Liposome for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Amphotericin B Liposome for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Amphotericin B Liposome for Injection Sales Growth
4.4 APAC Amphotericin B Liposome for Injection Sales Growth
4.5 Europe Amphotericin B Liposome for Injection Sales Growth
4.6 Middle East & Africa Amphotericin B Liposome for Injection Sales Growth
5 AMERICAS
5.1 Americas Amphotericin B Liposome for Injection Sales by Country
5.1.1 Americas Amphotericin B Liposome for Injection Sales by Country (2019-2024)
5.1.2 Americas Amphotericin B Liposome for Injection Revenue by Country (2019-2024)
5.2 Americas Amphotericin B Liposome for Injection Sales by Specification (2019-2024)
5.3 Americas Amphotericin B Liposome for Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amphotericin B Liposome for Injection Sales by Region
6.1.1 APAC Amphotericin B Liposome for Injection Sales by Region (2019-2024)
6.1.2 APAC Amphotericin B Liposome for Injection Revenue by Region (2019-2024)
6.2 APAC Amphotericin B Liposome for Injection Sales by Specification (2019-2024)
6.3 APAC Amphotericin B Liposome for Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amphotericin B Liposome for Injection by Country
7.1.1 Europe Amphotericin B Liposome for Injection Sales by Country (2019-2024)
7.1.2 Europe Amphotericin B Liposome for Injection Revenue by Country (2019-2024)
7.2 Europe Amphotericin B Liposome for Injection Sales by Specification (2019-2024)
7.3 Europe Amphotericin B Liposome for Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amphotericin B Liposome for Injection by Country
8.1.1 Middle East & Africa Amphotericin B Liposome for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Amphotericin B Liposome for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Amphotericin B Liposome for Injection Sales by Specification (2019-2024)
8.3 Middle East & Africa Amphotericin B Liposome for Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amphotericin B Liposome for Injection
10.3 Manufacturing Process Analysis of Amphotericin B Liposome for Injection
10.4 Industry Chain Structure of Amphotericin B Liposome for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amphotericin B Liposome for Injection Distributors
11.3 Amphotericin B Liposome for Injection Customer
12 WORLD FORECAST REVIEW FOR AMPHOTERICIN B LIPOSOME FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Amphotericin B Liposome for Injection Market Size Forecast by Region
12.1.1 Global Amphotericin B Liposome for Injection Forecast by Region (2025-2030)
12.1.2 Global Amphotericin B Liposome for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Amphotericin B Liposome for Injection Forecast by Specification (2025-2030)
12.7 Global Amphotericin B Liposome for Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Amphotericin B Liposome for Injection Product Portfolios and Specifications
13.1.3 Gilead Sciences Amphotericin B Liposome for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 SPH New Asia Pharmaceuticals
13.2.1 SPH New Asia Pharmaceuticals Company Information
13.2.2 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Product Portfolios and Specifications
13.2.3 SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 SPH New Asia Pharmaceuticals Main Business Overview
13.2.5 SPH New Asia Pharmaceuticals Latest Developments
13.3 Jemincare
13.3.1 Jemincare Company Information
13.3.2 Jemincare Amphotericin B Liposome for Injection Product Portfolios and Specifications
13.3.3 Jemincare Amphotericin B Liposome for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Jemincare Main Business Overview
13.3.5 Jemincare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Amphotericin B Liposome for Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Amphotericin B Liposome for Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 2mg
Table 4. Major Players of 10mg
Table 5. Major Players of 50mg
Table 6. Global Amphotericin B Liposome for Injection Sales by Specification (2019-2024) & (K Units)
Table 7. Global Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
Table 8. Global Amphotericin B Liposome for Injection Revenue by Specification (2019-2024) & ($ million)
Table 9. Global Amphotericin B Liposome for Injection Revenue Market Share by Specification (2019-2024)
Table 10. Global Amphotericin B Liposome for Injection Sale Price by Specification (2019-2024) & (US$/Unit)
Table 11. Global Amphotericin B Liposome for Injection Sale by Application (2019-2024) & (K Units)
Table 12. Global Amphotericin B Liposome for Injection Sale Market Share by Application (2019-2024)
Table 13. Global Amphotericin B Liposome for Injection Revenue by Application (2019-2024) & ($ million)
Table 14. Global Amphotericin B Liposome for Injection Revenue Market Share by Application (2019-2024)
Table 15. Global Amphotericin B Liposome for Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Amphotericin B Liposome for Injection Sales by Company (2019-2024) & (K Units)
Table 17. Global Amphotericin B Liposome for Injection Sales Market Share by Company (2019-2024)
Table 18. Global Amphotericin B Liposome for Injection Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Amphotericin B Liposome for Injection Revenue Market Share by Company (2019-2024)
Table 20. Global Amphotericin B Liposome for Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Amphotericin B Liposome for Injection Producing Area Distribution and Sales Area
Table 22. Players Amphotericin B Liposome for Injection Products Offered
Table 23. Amphotericin B Liposome for Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Amphotericin B Liposome for Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Amphotericin B Liposome for Injection Sales Market Share Geographic Region (2019-2024)
Table 28. Global Amphotericin B Liposome for Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Amphotericin B Liposome for Injection Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Amphotericin B Liposome for Injection Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Amphotericin B Liposome for Injection Sales Market Share by Country/Region (2019-2024)
Table 32. Global Amphotericin B Liposome for Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Amphotericin B Liposome for Injection Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Amphotericin B Liposome for Injection Sales by Country (2019-2024) & (K Units)
Table 35. Americas Amphotericin B Liposome for Injection Sales Market Share by Country (2019-2024)
Table 36. Americas Amphotericin B Liposome for Injection Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Amphotericin B Liposome for Injection Sales by Specification (2019-2024) & (K Units)
Table 38. Americas Amphotericin B Liposome for Injection Sales by Application (2019-2024) & (K Units)
Table 39. APAC Amphotericin B Liposome for Injection Sales by Region (2019-2024) & (K Units)
Table 40. APAC Amphotericin B Liposome for Injection Sales Market Share by Region (2019-2024)
Table 41. APAC Amphotericin B Liposome for Injection Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Amphotericin B Liposome for Injection Sales by Specification (2019-2024) & (K Units)
Table 43. APAC Amphotericin B Liposome for Injection Sales by Application (2019-2024) & (K Units)
Table 44. Europe Amphotericin B Liposome for Injection Sales by Country (2019-2024) & (K Units)
Table 45. Europe Amphotericin B Liposome for Injection Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Amphotericin B Liposome for Injection Sales by Specification (2019-2024) & (K Units)
Table 47. Europe Amphotericin B Liposome for Injection Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Amphotericin B Liposome for Injection Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Amphotericin B Liposome for Injection Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Amphotericin B Liposome for Injection Sales by Specification (2019-2024) & (K Units)
Table 51. Middle East & Africa Amphotericin B Liposome for Injection Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Amphotericin B Liposome for Injection
Table 53. Key Market Challenges & Risks of Amphotericin B Liposome for Injection
Table 54. Key Industry Trends of Amphotericin B Liposome for Injection
Table 55. Amphotericin B Liposome for Injection Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Amphotericin B Liposome for Injection Distributors List
Table 58. Amphotericin B Liposome for Injection Customer List
Table 59. Global Amphotericin B Liposome for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global Amphotericin B Liposome for Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Amphotericin B Liposome for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas Amphotericin B Liposome for Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Amphotericin B Liposome for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC Amphotericin B Liposome for Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Amphotericin B Liposome for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe Amphotericin B Liposome for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Amphotericin B Liposome for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Amphotericin B Liposome for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Amphotericin B Liposome for Injection Sales Forecast by Specification (2025-2030) & (K Units)
Table 70. Global Amphotericin B Liposome for Injection Revenue Forecast by Specification (2025-2030) & ($ millions)
Table 71. Global Amphotericin B Liposome for Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global Amphotericin B Liposome for Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Gilead Sciences Basic Information, Amphotericin B Liposome for Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. Gilead Sciences Amphotericin B Liposome for Injection Product Portfolios and Specifications
Table 75. Gilead Sciences Amphotericin B Liposome for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Gilead Sciences Main Business
Table 77. Gilead Sciences Latest Developments
Table 78. SPH New Asia Pharmaceuticals Basic Information, Amphotericin B Liposome for Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Product Portfolios and Specifications
Table 80. SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. SPH New Asia Pharmaceuticals Main Business
Table 82. SPH New Asia Pharmaceuticals Latest Developments
Table 83. Jemincare Basic Information, Amphotericin B Liposome for Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Jemincare Amphotericin B Liposome for Injection Product Portfolios and Specifications
Table 85. Jemincare Amphotericin B Liposome for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Jemincare Main Business
Table 87. Jemincare Latest Developments
Table 1. Amphotericin B Liposome for Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Amphotericin B Liposome for Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 2mg
Table 4. Major Players of 10mg
Table 5. Major Players of 50mg
Table 6. Global Amphotericin B Liposome for Injection Sales by Specification (2019-2024) & (K Units)
Table 7. Global Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
Table 8. Global Amphotericin B Liposome for Injection Revenue by Specification (2019-2024) & ($ million)
Table 9. Global Amphotericin B Liposome for Injection Revenue Market Share by Specification (2019-2024)
Table 10. Global Amphotericin B Liposome for Injection Sale Price by Specification (2019-2024) & (US$/Unit)
Table 11. Global Amphotericin B Liposome for Injection Sale by Application (2019-2024) & (K Units)
Table 12. Global Amphotericin B Liposome for Injection Sale Market Share by Application (2019-2024)
Table 13. Global Amphotericin B Liposome for Injection Revenue by Application (2019-2024) & ($ million)
Table 14. Global Amphotericin B Liposome for Injection Revenue Market Share by Application (2019-2024)
Table 15. Global Amphotericin B Liposome for Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Amphotericin B Liposome for Injection Sales by Company (2019-2024) & (K Units)
Table 17. Global Amphotericin B Liposome for Injection Sales Market Share by Company (2019-2024)
Table 18. Global Amphotericin B Liposome for Injection Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Amphotericin B Liposome for Injection Revenue Market Share by Company (2019-2024)
Table 20. Global Amphotericin B Liposome for Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Amphotericin B Liposome for Injection Producing Area Distribution and Sales Area
Table 22. Players Amphotericin B Liposome for Injection Products Offered
Table 23. Amphotericin B Liposome for Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Amphotericin B Liposome for Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Amphotericin B Liposome for Injection Sales Market Share Geographic Region (2019-2024)
Table 28. Global Amphotericin B Liposome for Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Amphotericin B Liposome for Injection Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Amphotericin B Liposome for Injection Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Amphotericin B Liposome for Injection Sales Market Share by Country/Region (2019-2024)
Table 32. Global Amphotericin B Liposome for Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Amphotericin B Liposome for Injection Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Amphotericin B Liposome for Injection Sales by Country (2019-2024) & (K Units)
Table 35. Americas Amphotericin B Liposome for Injection Sales Market Share by Country (2019-2024)
Table 36. Americas Amphotericin B Liposome for Injection Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Amphotericin B Liposome for Injection Sales by Specification (2019-2024) & (K Units)
Table 38. Americas Amphotericin B Liposome for Injection Sales by Application (2019-2024) & (K Units)
Table 39. APAC Amphotericin B Liposome for Injection Sales by Region (2019-2024) & (K Units)
Table 40. APAC Amphotericin B Liposome for Injection Sales Market Share by Region (2019-2024)
Table 41. APAC Amphotericin B Liposome for Injection Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Amphotericin B Liposome for Injection Sales by Specification (2019-2024) & (K Units)
Table 43. APAC Amphotericin B Liposome for Injection Sales by Application (2019-2024) & (K Units)
Table 44. Europe Amphotericin B Liposome for Injection Sales by Country (2019-2024) & (K Units)
Table 45. Europe Amphotericin B Liposome for Injection Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Amphotericin B Liposome for Injection Sales by Specification (2019-2024) & (K Units)
Table 47. Europe Amphotericin B Liposome for Injection Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Amphotericin B Liposome for Injection Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Amphotericin B Liposome for Injection Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Amphotericin B Liposome for Injection Sales by Specification (2019-2024) & (K Units)
Table 51. Middle East & Africa Amphotericin B Liposome for Injection Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Amphotericin B Liposome for Injection
Table 53. Key Market Challenges & Risks of Amphotericin B Liposome for Injection
Table 54. Key Industry Trends of Amphotericin B Liposome for Injection
Table 55. Amphotericin B Liposome for Injection Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Amphotericin B Liposome for Injection Distributors List
Table 58. Amphotericin B Liposome for Injection Customer List
Table 59. Global Amphotericin B Liposome for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global Amphotericin B Liposome for Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Amphotericin B Liposome for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas Amphotericin B Liposome for Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Amphotericin B Liposome for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC Amphotericin B Liposome for Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Amphotericin B Liposome for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe Amphotericin B Liposome for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Amphotericin B Liposome for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Amphotericin B Liposome for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Amphotericin B Liposome for Injection Sales Forecast by Specification (2025-2030) & (K Units)
Table 70. Global Amphotericin B Liposome for Injection Revenue Forecast by Specification (2025-2030) & ($ millions)
Table 71. Global Amphotericin B Liposome for Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global Amphotericin B Liposome for Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. Gilead Sciences Basic Information, Amphotericin B Liposome for Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. Gilead Sciences Amphotericin B Liposome for Injection Product Portfolios and Specifications
Table 75. Gilead Sciences Amphotericin B Liposome for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. Gilead Sciences Main Business
Table 77. Gilead Sciences Latest Developments
Table 78. SPH New Asia Pharmaceuticals Basic Information, Amphotericin B Liposome for Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Product Portfolios and Specifications
Table 80. SPH New Asia Pharmaceuticals Amphotericin B Liposome for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. SPH New Asia Pharmaceuticals Main Business
Table 82. SPH New Asia Pharmaceuticals Latest Developments
Table 83. Jemincare Basic Information, Amphotericin B Liposome for Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Jemincare Amphotericin B Liposome for Injection Product Portfolios and Specifications
Table 85. Jemincare Amphotericin B Liposome for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Jemincare Main Business
Table 87. Jemincare Latest Developments
LIST OF FIGURES
Figure 1. Picture of Amphotericin B Liposome for Injection
Figure 2. Amphotericin B Liposome for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amphotericin B Liposome for Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Amphotericin B Liposome for Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Amphotericin B Liposome for Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Amphotericin B Liposome for Injection Sales Market Share by Country/Region (2023)
Figure 10. Amphotericin B Liposome for Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 2mg
Figure 12. Product Picture of 10mg
Figure 13. Product Picture of 50mg
Figure 14. Global Amphotericin B Liposome for Injection Sales Market Share by Specification in 2023
Figure 15. Global Amphotericin B Liposome for Injection Revenue Market Share by Specification (2019-2024)
Figure 16. Amphotericin B Liposome for Injection Consumed in Hospital
Figure 17. Global Amphotericin B Liposome for Injection Market: Hospital (2019-2024) & (K Units)
Figure 18. Amphotericin B Liposome for Injection Consumed in Clinic
Figure 19. Global Amphotericin B Liposome for Injection Market: Clinic (2019-2024) & (K Units)
Figure 20. Amphotericin B Liposome for Injection Consumed in Others
Figure 21. Global Amphotericin B Liposome for Injection Market: Others (2019-2024) & (K Units)
Figure 22. Global Amphotericin B Liposome for Injection Sale Market Share by Application (2023)
Figure 23. Global Amphotericin B Liposome for Injection Revenue Market Share by Application in 2023
Figure 24. Amphotericin B Liposome for Injection Sales by Company in 2023 (K Units)
Figure 25. Global Amphotericin B Liposome for Injection Sales Market Share by Company in 2023
Figure 26. Amphotericin B Liposome for Injection Revenue by Company in 2023 ($ millions)
Figure 27. Global Amphotericin B Liposome for Injection Revenue Market Share by Company in 2023
Figure 28. Global Amphotericin B Liposome for Injection Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Amphotericin B Liposome for Injection Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Amphotericin B Liposome for Injection Sales 2019-2024 (K Units)
Figure 31. Americas Amphotericin B Liposome for Injection Revenue 2019-2024 ($ millions)
Figure 32. APAC Amphotericin B Liposome for Injection Sales 2019-2024 (K Units)
Figure 33. APAC Amphotericin B Liposome for Injection Revenue 2019-2024 ($ millions)
Figure 34. Europe Amphotericin B Liposome for Injection Sales 2019-2024 (K Units)
Figure 35. Europe Amphotericin B Liposome for Injection Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Amphotericin B Liposome for Injection Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Amphotericin B Liposome for Injection Revenue 2019-2024 ($ millions)
Figure 38. Americas Amphotericin B Liposome for Injection Sales Market Share by Country in 2023
Figure 39. Americas Amphotericin B Liposome for Injection Revenue Market Share by Country (2019-2024)
Figure 40. Americas Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
Figure 41. Americas Amphotericin B Liposome for Injection Sales Market Share by Application (2019-2024)
Figure 42. United States Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Amphotericin B Liposome for Injection Sales Market Share by Region in 2023
Figure 47. APAC Amphotericin B Liposome for Injection Revenue Market Share by Region (2019-2024)
Figure 48. APAC Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
Figure 49. APAC Amphotericin B Liposome for Injection Sales Market Share by Application (2019-2024)
Figure 50. China Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. India Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. China Taiwan Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Amphotericin B Liposome for Injection Sales Market Share by Country in 2023
Figure 58. Europe Amphotericin B Liposome for Injection Revenue Market Share by Country (2019-2024)
Figure 59. Europe Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
Figure 60. Europe Amphotericin B Liposome for Injection Sales Market Share by Application (2019-2024)
Figure 61. Germany Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 62. France Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Amphotericin B Liposome for Injection Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
Figure 68. Middle East & Africa Amphotericin B Liposome for Injection Sales Market Share by Application (2019-2024)
Figure 69. Egypt Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 72. Turkey Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Amphotericin B Liposome for Injection in 2023
Figure 75. Manufacturing Process Analysis of Amphotericin B Liposome for Injection
Figure 76. Industry Chain Structure of Amphotericin B Liposome for Injection
Figure 77. Channels of Distribution
Figure 78. Global Amphotericin B Liposome for Injection Sales Market Forecast by Region (2025-2030)
Figure 79. Global Amphotericin B Liposome for Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Amphotericin B Liposome for Injection Sales Market Share Forecast by Specification (2025-2030)
Figure 81. Global Amphotericin B Liposome for Injection Revenue Market Share Forecast by Specification (2025-2030)
Figure 82. Global Amphotericin B Liposome for Injection Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Amphotericin B Liposome for Injection Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Amphotericin B Liposome for Injection
Figure 2. Amphotericin B Liposome for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amphotericin B Liposome for Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Amphotericin B Liposome for Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Amphotericin B Liposome for Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Amphotericin B Liposome for Injection Sales Market Share by Country/Region (2023)
Figure 10. Amphotericin B Liposome for Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 2mg
Figure 12. Product Picture of 10mg
Figure 13. Product Picture of 50mg
Figure 14. Global Amphotericin B Liposome for Injection Sales Market Share by Specification in 2023
Figure 15. Global Amphotericin B Liposome for Injection Revenue Market Share by Specification (2019-2024)
Figure 16. Amphotericin B Liposome for Injection Consumed in Hospital
Figure 17. Global Amphotericin B Liposome for Injection Market: Hospital (2019-2024) & (K Units)
Figure 18. Amphotericin B Liposome for Injection Consumed in Clinic
Figure 19. Global Amphotericin B Liposome for Injection Market: Clinic (2019-2024) & (K Units)
Figure 20. Amphotericin B Liposome for Injection Consumed in Others
Figure 21. Global Amphotericin B Liposome for Injection Market: Others (2019-2024) & (K Units)
Figure 22. Global Amphotericin B Liposome for Injection Sale Market Share by Application (2023)
Figure 23. Global Amphotericin B Liposome for Injection Revenue Market Share by Application in 2023
Figure 24. Amphotericin B Liposome for Injection Sales by Company in 2023 (K Units)
Figure 25. Global Amphotericin B Liposome for Injection Sales Market Share by Company in 2023
Figure 26. Amphotericin B Liposome for Injection Revenue by Company in 2023 ($ millions)
Figure 27. Global Amphotericin B Liposome for Injection Revenue Market Share by Company in 2023
Figure 28. Global Amphotericin B Liposome for Injection Sales Market Share by Geographic Region (2019-2024)
Figure 29. Global Amphotericin B Liposome for Injection Revenue Market Share by Geographic Region in 2023
Figure 30. Americas Amphotericin B Liposome for Injection Sales 2019-2024 (K Units)
Figure 31. Americas Amphotericin B Liposome for Injection Revenue 2019-2024 ($ millions)
Figure 32. APAC Amphotericin B Liposome for Injection Sales 2019-2024 (K Units)
Figure 33. APAC Amphotericin B Liposome for Injection Revenue 2019-2024 ($ millions)
Figure 34. Europe Amphotericin B Liposome for Injection Sales 2019-2024 (K Units)
Figure 35. Europe Amphotericin B Liposome for Injection Revenue 2019-2024 ($ millions)
Figure 36. Middle East & Africa Amphotericin B Liposome for Injection Sales 2019-2024 (K Units)
Figure 37. Middle East & Africa Amphotericin B Liposome for Injection Revenue 2019-2024 ($ millions)
Figure 38. Americas Amphotericin B Liposome for Injection Sales Market Share by Country in 2023
Figure 39. Americas Amphotericin B Liposome for Injection Revenue Market Share by Country (2019-2024)
Figure 40. Americas Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
Figure 41. Americas Amphotericin B Liposome for Injection Sales Market Share by Application (2019-2024)
Figure 42. United States Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 43. Canada Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 44. Mexico Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 45. Brazil Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 46. APAC Amphotericin B Liposome for Injection Sales Market Share by Region in 2023
Figure 47. APAC Amphotericin B Liposome for Injection Revenue Market Share by Region (2019-2024)
Figure 48. APAC Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
Figure 49. APAC Amphotericin B Liposome for Injection Sales Market Share by Application (2019-2024)
Figure 50. China Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 51. Japan Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. South Korea Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. Southeast Asia Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. India Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. Australia Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. China Taiwan Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 57. Europe Amphotericin B Liposome for Injection Sales Market Share by Country in 2023
Figure 58. Europe Amphotericin B Liposome for Injection Revenue Market Share by Country (2019-2024)
Figure 59. Europe Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
Figure 60. Europe Amphotericin B Liposome for Injection Sales Market Share by Application (2019-2024)
Figure 61. Germany Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 62. France Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. UK Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 64. Italy Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 65. Russia Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 66. Middle East & Africa Amphotericin B Liposome for Injection Sales Market Share by Country (2019-2024)
Figure 67. Middle East & Africa Amphotericin B Liposome for Injection Sales Market Share by Specification (2019-2024)
Figure 68. Middle East & Africa Amphotericin B Liposome for Injection Sales Market Share by Application (2019-2024)
Figure 69. Egypt Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. South Africa Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. Israel Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 72. Turkey Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 73. GCC Countries Amphotericin B Liposome for Injection Revenue Growth 2019-2024 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Amphotericin B Liposome for Injection in 2023
Figure 75. Manufacturing Process Analysis of Amphotericin B Liposome for Injection
Figure 76. Industry Chain Structure of Amphotericin B Liposome for Injection
Figure 77. Channels of Distribution
Figure 78. Global Amphotericin B Liposome for Injection Sales Market Forecast by Region (2025-2030)
Figure 79. Global Amphotericin B Liposome for Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Amphotericin B Liposome for Injection Sales Market Share Forecast by Specification (2025-2030)
Figure 81. Global Amphotericin B Liposome for Injection Revenue Market Share Forecast by Specification (2025-2030)
Figure 82. Global Amphotericin B Liposome for Injection Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Amphotericin B Liposome for Injection Revenue Market Share Forecast by Application (2025-2030)
